APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Non-Steroidal Anti-Inflammatory Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Growth and Trends Forecast to 2032

28 December 2025109 pages

Choose your research edition.

Industry ResearchDermatological Non-Steroidal Anti-Inflammatory Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dermatological Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs include LEAD CHEMICAL, Merck KGaA, Verona Pharma, Arcutis, GlaxoSmithKline PLc, Huadong Medicine, Pfizer Inc., Roche and MSD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dermatological Non-Steroidal Anti-Inflammatory Drugs market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatological Non-Steroidal Anti-Inflammatory Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Company

LEAD CHEMICAL

Merck KGaA

Verona Pharma

Arcutis

GlaxoSmithKline PLc

Huadong Medicine

Pfizer Inc.

Roche

MSD

Genzyme Co.

Shapuaisi

Sato Pharmaceutical

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Type

Ketotifen

Ketoconazole

Phthalin Butan

Tacrolimus

Prednisone

Loratadine

Cyclosporine A

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Application

Hospital

Clinic

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Non-Steroidal Anti-Inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Non-Steroidal Anti-Inflammatory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatological Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dermatological Non-Steroidal Anti-Inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ketotifen Table 2. Major Company of Ketoconazole Table 3. Major Company of Phthalin Butan Table 4. Major Company of Tacrolimus Table 5. Major Company of Prednisone Table 6. Major Company of Loratadine Table 7. Major Company of Cyclosporine A Table 8. Major Company of Others Table 9. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 11. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type (2021-2026) Table 12. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 13. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type (2021-2026) Table 14. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2026) & (US$/Unit) Table 15. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 16. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type (2027-2032) Table 17. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (US$ Million) Table 18. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type (2027-2032) Table 19. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2027-2032) & (US$/Unit) Table 20. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 21. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 23. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 25. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 27. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 29. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (US$ Million) Table 30. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends Table 31. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers Table 32. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges Table 33. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints Table 34. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Company (2021-2026) & (Units) Table 37. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Company (2021-2026) Table 38. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 39. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Major Company Production Sites and Headquarters Table 41. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Company, Product Type & Application Table 42. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2021-2026) & (Units) Table 47. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Region (2021-2026) Table 48. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2021-2026) & (US$ Million) Table 49. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Region (2021-2026) Table 50. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2027-2032) & (Units) Table 52. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Region (2027-2032) Table 53. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2027-2032) & (US$ Million) Table 54. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Region (2027-2032) Table 55. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 56. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 58. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application (2021-2026) Table 59. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 60. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application (2021-2026) Table 61. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2026) & (US$/Unit) Table 62. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 63. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application (2027-2032) Table 64. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (US$ Million) Table 65. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application (2027-2032) Table 66. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2027-2032) & (US$/Unit) Table 67. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 68. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 70. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 72. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 74. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 76. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (US$ Million) Table 77. LEAD CHEMICAL Company Information Table 78. LEAD CHEMICAL Business Overview Table 79. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 81. LEAD CHEMICAL Recent Development Table 82. Merck KGaA Company Information Table 83. Merck KGaA Business Overview Table 84. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 86. Merck KGaA Recent Development Table 87. Verona Pharma Company Information Table 88. Verona Pharma Business Overview Table 89. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 91. Verona Pharma Recent Development Table 92. Arcutis Company Information Table 93. Arcutis Business Overview Table 94. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 96. Arcutis Recent Development Table 97. GlaxoSmithKline PLc Company Information Table 98. GlaxoSmithKline PLc Business Overview Table 99. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 101. GlaxoSmithKline PLc Recent Development Table 102. Huadong Medicine Company Information Table 103. Huadong Medicine Business Overview Table 104. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 106. Huadong Medicine Recent Development Table 107. Pfizer Inc. Company Information Table 108. Pfizer Inc. Business Overview Table 109. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 111. Pfizer Inc. Recent Development Table 112. Roche Company Information Table 113. Roche Business Overview Table 114. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 116. Roche Recent Development Table 117. MSD Company Information Table 118. MSD Business Overview Table 119. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 121. MSD Recent Development Table 122. Genzyme Co. Company Information Table 123. Genzyme Co. Business Overview Table 124. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 126. Genzyme Co. Recent Development Table 127. Shapuaisi Company Information Table 128. Shapuaisi Business Overview Table 129. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 131. Shapuaisi Recent Development Table 132. Sato Pharmaceutical Company Information Table 133. Sato Pharmaceutical Business Overview Table 134. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 136. Sato Pharmaceutical Recent Development Table 137. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 138. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 139. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026) Table 140. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032) & (Units) Table 141. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2021-2026) Table 145. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Country (2027-2032) Table 147. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 148. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 149. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026) Table 150. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032) & (Units) Table 151. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2021-2026) Table 155. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 159. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032) & (Units) Table 161. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2021-2026) Table 165. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Country (2027-2032) Table 167. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 168. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 169. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026) Table 170. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032) & (Units) Table 171. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2021-2026) Table 175. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 179. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032) & (Units) Table 181. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2021-2026) Table 185. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors List Table 190. Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Dermatological Non-Steroidal Anti-Inflammatory Drugs Image Figure 2. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2021-2032) & (Units) Figure 5. Ketotifen Image Figure 6. Global Ketotifen Sales YoY Growth (2021-2032) & (Units) Figure 7. Ketoconazole Image Figure 8. Global Ketoconazole Sales YoY Growth (2021-2032) & (Units) Figure 9. Phthalin Butan Image Figure 10. Global Phthalin Butan Sales YoY Growth (2021-2032) & (Units) Figure 11. Tacrolimus Image Figure 12. Global Tacrolimus Sales YoY Growth (2021-2032) & (Units) Figure 13. Prednisone Image Figure 14. Global Prednisone Sales YoY Growth (2021-2032) & (Units) Figure 15. Loratadine Image Figure 16. Global Loratadine Sales YoY Growth (2021-2032) & (Units) Figure 17. Cyclosporine A Image Figure 18. Global Cyclosporine A Sales YoY Growth (2021-2032) & (Units) Figure 19. Others Image Figure 20. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 21. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Type 2025 VS 2032 Figure 23. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type in 2025 Figure 24. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type in 2025 Figure 25. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type in 2025 Figure 29. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Dermatological Non-Steroidal Anti-Inflammatory Drugs Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Hospital Image Figure 36. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 37. Clinic Image Figure 38. Global Clinic Sales YoY Growth (2021-2032) & (Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 41. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Application 2025 VS 2032 Figure 43. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 62. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 66. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 70. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Ketotifen
  • Ketoconazole
  • Phthalin Butan
  • Tacrolimus
  • Prednisone
  • Loratadine
  • Cyclosporine A
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • LEAD CHEMICAL
  • Merck KGaA
  • Verona Pharma
  • Arcutis
  • GlaxoSmithKline PLc
  • Huadong Medicine
  • Pfizer Inc.
  • Roche
  • MSD
  • Genzyme Co.
  • Shapuaisi
  • Sato Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Type
  6. 1.3.1 Ketotifen
  7. 1.3.2 Ketoconazole
  8. 1.3.3 Phthalin Butan
  9. 1.3.4 Tacrolimus
  10. 1.3.5 Prednisone
  11. 1.3.6 Loratadine
  12. 1.3.7 Cyclosporine A
  13. 1.3.8 Others
  14. 1.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  15. 1.4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends
  2. 2.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers
  3. 2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges
  4. 2.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Dermatological Non-Steroidal Anti-Inflammatory Drugs Price (2021-2026)
  4. 3.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Company, Product Type & Application
  7. 3.7 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatological Non-Steroidal Anti-Inflammatory Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatological Non-Steroidal Anti-Inflammatory Drugs Tier 1, Tier 2, and Tier 3
4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Regional Status and Outlook
  1. 4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Region
  3. 4.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dermatological Non-Steroidal Anti-Inflammatory Drugs by Application
  1. 5.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 5.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 LEAD CHEMICAL
  2. 6.1.1 LEAD CHEMICAL Company Information
  3. 6.1.2 LEAD CHEMICAL Business Overview
  4. 6.1.3 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  6. 6.1.5 LEAD CHEMICAL Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 Verona Pharma
  14. 6.3.1 Verona Pharma Company Information
  15. 6.3.2 Verona Pharma Business Overview
  16. 6.3.3 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  18. 6.3.5 Verona Pharma Recent Developments
  19. 6.4 Arcutis
  20. 6.4.1 Arcutis Company Information
  21. 6.4.2 Arcutis Business Overview
  22. 6.4.3 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  24. 6.4.5 Arcutis Recent Developments
  25. 6.5 GlaxoSmithKline PLc
  26. 6.5.1 GlaxoSmithKline PLc Company Information
  27. 6.5.2 GlaxoSmithKline PLc Business Overview
  28. 6.5.3 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline PLc Recent Developments
  31. 6.6 Huadong Medicine
  32. 6.6.1 Huadong Medicine Company Information
  33. 6.6.2 Huadong Medicine Business Overview
  34. 6.6.3 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  36. 6.6.5 Huadong Medicine Recent Developments
  37. 6.7 Pfizer Inc.
  38. 6.7.1 Pfizer Inc. Company Information
  39. 6.7.2 Pfizer Inc. Business Overview
  40. 6.7.3 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  42. 6.7.5 Pfizer Inc. Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 MSD
  50. 6.9.1 MSD Company Information
  51. 6.9.2 MSD Business Overview
  52. 6.9.3 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  54. 6.9.5 MSD Recent Developments
  55. 6.10 Genzyme Co.
  56. 6.10.1 Genzyme Co. Company Information
  57. 6.10.2 Genzyme Co. Business Overview
  58. 6.10.3 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  60. 6.10.5 Genzyme Co. Recent Developments
  61. 6.11 Shapuaisi
  62. 6.11.1 Shapuaisi Company Information
  63. 6.11.2 Shapuaisi Business Overview
  64. 6.11.3 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  66. 6.11.5 Shapuaisi Recent Developments
  67. 6.12 Sato Pharmaceutical
  68. 6.12.1 Sato Pharmaceutical Company Information
  69. 6.12.2 Sato Pharmaceutical Business Overview
  70. 6.12.3 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  72. 6.12.5 Sato Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country
  2. 7.1.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  6. 7.2.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country
  2. 8.1.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  6. 8.2.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country
  2. 10.1.1 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  6. 10.2.1 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain Analysis
  2. 12.1.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process
  7. 12.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors
  10. 12.2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst